About Asia Dengue Voice and Action (ADVA)

Established in 2012, ADVA began as Asia Dengue Vaccination Advocacy—a scientific working group dedicated to translating dengue vaccine science into actionable strategies for policymakers, healthcare workers, and communities. The first workshop was held in Bangkok from 21st to23rd September 2012 where clinicians, public health experts, and delegates from health advocacy groups in the Association of Southeast Asian Nations (ASEAN) region were invited to share their expertise on their fight against dengue. Today, we’ve evolved into Asia Dengue Voice and Action, reflecting our broader commitment to holistic dengue prevention and control across Asia. While vaccination remains a critical tool, our mission now addresses the full spectrum of dengue management to achieve the WHO target of zero dengue deaths by 2030.
Our Evolution: From Vaccination Advocacy to Integrated Action

Initially focused on vaccine introduction strategies, ADVA now champions a multidimensional approach developed through collaboration with governments, academia, clinicians, NGOs, and industry partners. This shift recognizes that defeating dengue requires more than medical solutions—it demands environmental stewardship, policy innovation, and community empowerment.

In June 2022, we convened experts from epidemiology, environmental science, digital health, and policy to establish the ADVA Dengue Task Force. This coalition drives our expanded mission:

ADVA’s Mission

  1. Science into Action: Translate dengue research into practical strategies for policymakers and healthcare systems
  2. Strengthen Health Infrastructure: Improve surveillance, diagnostics, and case management while addressing systemic gaps exposed by COVID-19
  3. Unite Stakeholders: Develop a regional blueprint for dengue management through collaboration with initiatives like V2V (Vaccine to Vaccination) and the Dengue Vaccine Initiative

Our Framework for Impact

The ADVA Task Force operates through six interconnected pillars:

  1. Policy & Governance
    • Shape equitable policies balancing dengue control with competing health priorities
    • Align regional efforts through our dengue management blueprint
  2. Data-Driven Solutions
    • Standardize diagnostics and build a robust Asia-Pacific dengue database
    • Guide resource allocation using epidemiological, environmental, and economic insights
  3. Health System Strengthening
    • Address infrastructure gaps in cold chains, pharmacovigilance, and vaccine distribution
    • Train healthcare professionals in outbreak response and case management
  4. Community Resilience
    • Mobilize grassroots action through youth engagement and civic partnerships
    • Combat vaccine hesitancy with science-backed education
  5. Environmental Strategy
    • Promote sustainable urban planning to disrupt mosquito breeding cycles
    • Integrate vector control with climate adaptation efforts
  6. Global Collaboration
    • Share best practices with global health models
    • Partner with industry to scale innovations in diagnostics and therapeutics

The Path Forward

Dengue is a collective challenge requiring coordinated action. Our regional blueprint—developed with input from governments, academia, and civil society—provides clear imperatives:

  • Prioritize context-specific solutions respecting Asia’s cultural and ecological diversity
  • Strengthen cross-border collaboration for outbreak preparedness
  • Maintain vaccine advocacy while expanding focus on prevention ecosystems

By uniting science, policy, and community action, ADVA is committed to turning the tide against dengue. Together, we can protect Asia’s future.

Join us in making zero dengue deaths by 2030 a reality.

ADVA’s Mission:

1) Translate the science of dengue vaccination into clinical insights and recommendations to policy makers, healthcare workers and the general public.
2) Make practical recommendations for the design and implementation of dengue management programs.

An Evolving Mission

At its inception, ADVA, in both its title and focus stood for Asia Dengue Vaccination Advocacy. This has evolved to take on a broader remit in not only representing the Voice of Dengue in Asia, but also committing itself to Action.

This shift of focus to voice and action underpins the evolved definition of ADVA: Asia Dengue Voice and Action.

Asia Dengue Voice and Action

With input from government, public health entities, academia, the clinical community, consumer health organisations and industry bodies, ADVA has taken up the challenge of consulting and developing a regional blueprint for dengue management.

This blueprint will provide a cohesive, central and actionable point of view on dengue management across Asia. The blueprint will formulate a key set of strategic imperatives, with supporting actions.

The challenge of dengue is a collective one. We trust that by collaborating widely with a broad range of stakeholders, this blueprint will be adopted by all stakeholders who will then prioritise the actions that will deliver on the strategic imperatives.

By generating well-informed, focused and co-ordinated actions across the region, we hope to have a significant impact on dengue in Asia.